The Zhitong Finance App learned that on October 9, Xiansheng Pharmaceutical (02096.HK) announced that it would spend HK$17.369.89 million to buy back 1.598 million shares. This is the company's fifth share repurchase since September. Such frequent and vigorous repurchase operations have sent a clear valuation signal: the company has firm confidence in its intrinsic value and medium- to long-term development prospects.

Zhitongcaijing · 2d ago
The Zhitong Finance App learned that on October 9, Xiansheng Pharmaceutical (02096.HK) announced that it would spend HK$17.369.89 million to buy back 1.598 million shares. This is the company's fifth share repurchase since September. Such frequent and vigorous repurchase operations have sent a clear valuation signal: the company has firm confidence in its intrinsic value and medium- to long-term development prospects.